BPH Global (ASX: BP8) is an Australian-listed company in the Healthcare sector with a market capitalisation of $3.7M and the 1736th-largest security on the ASX by market capitalisation. The BP8 share price is $0.002, up 0.00% today and up 0.00% over the past 12 months. Shares have traded between $0.001 and $0.003 over the past 52 weeks. In its most recent reported period (ending 30 June 2025), BPH Global reported revenue of $301,440 and a net loss of $1.0M.
About BPH Global Ltd
BPH Global Ltd, along with its associated entities, specializes in the procurement, production, promotion, and sale of traditional medicinal items. Its operational reach spans Australia, Singapore, China, and the broader Southeast Asian market. The company's diverse product range features both unprocessed and refined bird's nest offerings, alongside marine botanicals like Caulerpa Lentillifera (sea grapes) and various seaweeds. These products are utilized across multiple industries, including food, nutrition, healthcare, dietary supplements, cosmetics, and personal care. Headquartered in Melbourne, Australia, the company was founded in 1984 and transitioned to its current name, BPH Global Ltd, in June 2023, having previously been known as Stemcell United Limited.
CEO
Matthew Robert Leonard
